Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
International Journal of Antimicrobial Agents
|
August 21, 2007
The epidemiology and treatment of infections in cancer patients
Georg Maschmeyer, Antje Haas
Medical Mycology
|
November 10, 2018
Defining clinical failure for salvage studies
Georg Maschmeyer, Antje Haas
Future Microbiology
|
July 31, 2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections
Georg Maschmeyer, Antje Haas
Drugs
|
July 31, 2007
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients
Georg Maschmeyer, Antje Haas, Oliver A Cornely
British Journal of Haematology
|
April 22, 2008
Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients
Carsten Hirt, Frank Schüler, Thomas Kiefer, et al.
British Journal of Haematology
|
August 30, 2008
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial
Wolfram Pönisch, Marta Rozanski, Hartmut Goldschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group
Anja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study
Michael Herold, Antje Haas, Stefanie Srock, et al.
The Journal of Antimicrobial Chemotherapy
|
February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
Oliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
International Journal of Antimicrobial Agents
|
August 21, 2007
The epidemiology and treatment of infections in cancer patients
Georg Maschmeyer, Antje Haas
Medical Mycology
|
November 10, 2018
Defining clinical failure for salvage studies
Georg Maschmeyer, Antje Haas
Future Microbiology
|
July 31, 2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections
Georg Maschmeyer, Antje Haas
Drugs
|
July 31, 2007
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients
Georg Maschmeyer, Antje Haas, Oliver A Cornely
British Journal of Haematology
|
April 22, 2008
Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients
Carsten Hirt, Frank Schüler, Thomas Kiefer, et al.
British Journal of Haematology
|
August 30, 2008
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial
Wolfram Pönisch, Marta Rozanski, Hartmut Goldschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group
Anja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study
Michael Herold, Antje Haas, Stefanie Srock, et al.
The Journal of Antimicrobial Chemotherapy
|
February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
Oliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Page
of 1